...
search icon
bcda-img

Biocardia Inc Share Price

BCDA
NAQ
$1.13
-$0.03
(-2.59%)
1D
Industry: Biotechnology Sector: Health Care

Biocardia Inc Analyst Forecast

Biocardia Inc Share Price Chart

Biocardia Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$12.31M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
48.19K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.61
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1 L
$3.2 H
$1.13

About Biocardia Inc, Common Stock

BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States. The company's lead product candidate is CardiAMP, an autologous mononuclear cell therapy system in Phase III clinical trial for the treatment of ischemic heart failure with reduced ejection fraction and refractory angina resulting from chronic myocardial ischemia. It is also developing an allogeneic cells therapy platform, which is an investigational culture expanded bone marrow derived mesenchymal cell therapy in Phase I/II trial to treat ischemic heart failure and acute respiratory distress syndrome. In addition, the company offers the Helix biotherapeutic delivery system for minimally invasive targeted delivery of biologic agents to the heart; and Morph deflectable guides and sheaths products. It has collaboration agreements with CellProthera in the development of ProtheraCytes, which is currently under Phase II trial for the treatment of acute myocardial infarction. It also has a development and commercialization agreement with CART-Tech, B.V. for the development of Heart3D Fusion Imaging system. BioCardia, Inc. is based in Sunnyvale, California. more

Industry: BiotechnologySector: Health Care

Biocardia Inc Stock Returns

Time FrameBCDASectorS&P500
1-Week Return1.75%-0.26%0.42%
1-Month Return-10.77%1.2%1.02%
3-Month Return-9.38%3.86%4.93%
6-Month Return-36.61%14.37%7.32%
1-Year Return-52.07%6.82%12.16%
3-Year Return-96.64%20.71%71.63%
5-Year Return-98.15%37.78%76.95%
10-Year Return-99.09%135.17%252.5%

Biocardia Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue145.00K1.01M1.35M477.00K58.00K[{"date":"2020-12-31","value":10.72,"profit":true},{"date":"2021-12-31","value":75.07,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":35.28,"profit":true},{"date":"2024-12-31","value":4.29,"profit":true}]
Cost of Revenue4.00K640.00K11.90M7.73M4.39M[{"date":"2020-12-31","value":0.03,"profit":true},{"date":"2021-12-31","value":5.38,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":64.92,"profit":true},{"date":"2024-12-31","value":36.86,"profit":true}]
Gross Profit141.00K375.00K(10.55M)(7.25M)(4.33M)[{"date":"2020-12-31","value":37.6,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-2813.07,"profit":false},{"date":"2023-12-31","value":-1933.07,"profit":false},{"date":"2024-12-31","value":-1154.4,"profit":false}]
Gross Margin97.24%36.95%(780.25%)(1519.71%)(7463.79%)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":37.99,"profit":true},{"date":"2022-12-31","value":-802.39,"profit":false},{"date":"2023-12-31","value":-1562.82,"profit":false},{"date":"2024-12-31","value":-7675.53,"profit":false}]
Operating Expenses15.67M13.01M13.25M4.39M3.67M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":82.99,"profit":true},{"date":"2022-12-31","value":84.58,"profit":true},{"date":"2023-12-31","value":28.05,"profit":true},{"date":"2024-12-31","value":23.43,"profit":true}]
Operating Income(15.53M)(12.63M)(11.90M)(11.64M)(8.00M)[{"date":"2020-12-31","value":-1552900000,"profit":false},{"date":"2021-12-31","value":-1263000000,"profit":false},{"date":"2022-12-31","value":-1190100000,"profit":false},{"date":"2023-12-31","value":-1164400000,"profit":false},{"date":"2024-12-31","value":-800099900,"profit":false}]
Total Non-Operating Income/Expense543.00K16.00K---[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":2.95,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Pre-Tax Income(15.00M)(12.62M)(11.91M)(11.57M)(7.95M)[{"date":"2020-12-31","value":-1500400000,"profit":false},{"date":"2021-12-31","value":-1262300000,"profit":false},{"date":"2022-12-31","value":-1190700000,"profit":false},{"date":"2023-12-31","value":-1157100000,"profit":false},{"date":"2024-12-31","value":-794600000,"profit":false}]
Income Taxes1.00K(2.00K)6.00K243.10K(7.95M)[{"date":"2020-12-31","value":0.41,"profit":true},{"date":"2021-12-31","value":-0.82,"profit":false},{"date":"2022-12-31","value":2.47,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-3268.55,"profit":false}]
Income After Taxes(15.01M)(12.62M)---[{"date":"2020-12-31","value":-1500500000,"profit":false},{"date":"2021-12-31","value":-1262100000,"profit":false},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(15.00M)(12.62M)(11.91M)(11.57M)(7.95M)[{"date":"2020-12-31","value":-1500400000,"profit":false},{"date":"2021-12-31","value":-1262300000,"profit":false},{"date":"2022-12-31","value":-1190700000,"profit":false},{"date":"2023-12-31","value":-1157100000,"profit":false},{"date":"2024-12-31","value":-794600000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(15.00M)(12.62M)(11.91M)(11.57M)(7.95M)[{"date":"2020-12-31","value":-1500400000,"profit":false},{"date":"2021-12-31","value":-1262100000,"profit":false},{"date":"2022-12-31","value":-1191300000,"profit":false},{"date":"2023-12-31","value":-1157100000,"profit":false},{"date":"2024-12-31","value":-794600000,"profit":false}]
EPS (Diluted)(1.39)(0.74)(0.67)(0.55)(1.83)[{"date":"2020-12-31","value":-139,"profit":false},{"date":"2021-12-31","value":-74,"profit":false},{"date":"2022-12-31","value":-67,"profit":false},{"date":"2023-12-31","value":-55,"profit":false},{"date":"2024-12-31","value":-182.71,"profit":false}]

Biocardia Inc Ratios

Biocardia Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

BCDA
Cash Ratio 1.60
Current Ratio 1.62

Biocardia Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

BCDA
ROA (LTM) -86.45%
ROE (LTM) -317.47%

Biocardia Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

BCDA
Debt Ratio Lower is generally better. Negative is bad. 0.57
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.43

Biocardia Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

BCDA
Trailing PE NM
Forward PE NM
P/S (TTM) 3089.53
P/B 4.65
Price/FCF NM
EV/R 3111.70
EV/Ebitda NM
PEG NM

FAQs

What is Biocardia Inc share price today?

Biocardia Inc (BCDA) share price today is $1.13

Can Indians buy Biocardia Inc shares?

Yes, Indians can buy shares of Biocardia Inc (BCDA) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BCDA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Biocardia Inc be purchased?

Yes, you can purchase fractional shares of Biocardia Inc (BCDA) via the Vested app. You can start investing in Biocardia Inc (BCDA) with a minimum investment of $1.

How to invest in Biocardia Inc shares from India?

You can invest in shares of Biocardia Inc (BCDA) via Vested in three simple steps:

  • Click on Sign Up or Invest in BCDA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Biocardia Inc shares
What is Biocardia Inc 52-week high and low stock price?

The 52-week high price of Biocardia Inc (BCDA) is $3.2. The 52-week low price of Biocardia Inc (BCDA) is $1.

What is Biocardia Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Biocardia Inc (BCDA) is

What is Biocardia Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Biocardia Inc (BCDA) is 4.65

What is Biocardia Inc dividend yield?

The dividend yield of Biocardia Inc (BCDA) is 0.00%

What is the Market Cap of Biocardia Inc?

The market capitalization of Biocardia Inc (BCDA) is $12.31M

What is Biocardia Inc's stock symbol?

The stock symbol (or ticker) of Biocardia Inc is BCDA

How Can Investors Use Biocardia Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Biocardia Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Biocardia Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Biocardia Inc shares for Indian investors?

When investing in Biocardia Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Biocardia Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Biocardia Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Biocardia Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Biocardia Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top